Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04479514 · ClinicalTrials.gov registry record · Phase 2
Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy
A Phase 2 study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT04479514 is a Phase 2 study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 14 participants.
The verdict
NCT04479514, a Phase 2 study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
This research study is examining a preventive skin care regimen for children diagnosed with a brain tumor and receiving anti-cancer therapy with a MEK, Pan-RAF, or BRAF inhibitor.
Interventions
- OTHER Moisturizer
- OTHER Warm Baths or Showers
- DRUG SPF 30 or Higher Suncreen
- OTHER Sun Protective Clothing
- BEHAVIORAL Limited Sun Exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2025-02-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04479514
The ClinicalTrials.gov registry entry for NCT04479514 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Moisturizer is the first listed.
NCT04479514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04479514 about?
NCT04479514 is a clinical study titled "Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy". This research study is examining a preventive skin care regimen for children diagnosed with a brain tumor and receiving anti-cancer therapy with a MEK, Pan-RAF, or BRAF inhibitor.
What is the current status of trial NCT04479514?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2020-10-01. Estimated completion is 2025-02-15.
What interventions are being tested in trial NCT04479514?
The interventions under investigation include: Moisturizer (OTHER), Warm Baths or Showers (OTHER), SPF 30 or Higher Suncreen (DRUG), Sun Protective Clothing (OTHER), Limited Sun Exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT04479514?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.